TARPLIN, DOWNS & YOUNG, LLC for AMGEN INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
**see addendum pagePL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation S. 959 - Pharmaceutical Compounding Quality and Accountability Act, track and trace H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013, track and trace H.R. 3204 The Drug Quality and Security Act ***, no specific bill, Prescription Drug User Fee Act (PDUFA) and associated policies
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | — |
| JENNIFER B YOUNG | — |
Medicare/Medicaid MMM
**see addendum pageMedicare Coverage and Reimbursement Issues ***, no specific bill number, reimbursement issues, Medicare Part B reimbursement and coverage of dialysis products, discount cards
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. |
| MICHELLE P EASTON | Chief Health Counsel, Sen. Cmte. On Finance; |
| ISAAC A FORDJOUR | — |
| LINDA E TARPLIN | Congressman Billy Tauzin |
| JENNIFER B YOUNG | Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.